Incyte is whittling down its R&D pipeline, scrapping six discovery programs—one in a rare form of anemia and five in various cancers—to focus on eight remaining programs. The Jakafi maker’s remaining ...

The pile of discarded biotech R&D programs is getting bigger and bigger. Hutchmed, NightHawk Biosciences and NexImmune are the latest companies to add to the list, tossing out programs yesterday in ...

FRANKFURT AM MAIN, Germany--(BUSINESS WIRE)--Economies around the world are investing in robotics to support industry and society. But government research and development (R&D) programs are following ...

Eaton Corporation’s ETN operations will thrive on the back of its wide market reach and systematic R&D expenditures. This will create new products that are set to help ETN’s customers in efficient ...